"Ahead of this earnings release, the estimate revisions trend for C4 Therapeutics: favorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #2 (Buy) for the stock."
Hi looking 4 a win! You, I and subs have been watching C4 for awhile now. 80% inst ownership shows good faith. Two years from now is when I think I'll consider selling. Cccc, sprc, and lucy are my main long term interests I keep a close eye on. Good luck in your decisions looking!
You have the patience the strength and the passion
To achieve your ambitions your goals and your dreams.
All you need to do is try!
Market Data 
Markets 
AI
